FDA letters slew sponsored links

Share this article:

The FDA's 14 letters warning companies about sponsored links on search engines all but eliminated industry use of the media, according to ComScore.

Sponsored link exposures to US internet users fell by 59% within a week of March 26, when the untitled letters were issued, and were down 84% by the end of June. The letters said, in essence, that the sponsored links had failed to communicate appropriate risk information.  

“The FDA letters changed not only how pharmaceutical manufacturers are marketing online but what consumers are being exposed to when they search for health information,” said ComScore VP marketing solutions John Mangano.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.